All In MedTech

Device Trial Radar · NCT03403426

ReFlow Medical Wingman Catheter Wing-IT Clinical Trial

A Non-Randomized Study Evaluating the Use of the ReFlow Medical Wingman Catheter to Cross Chronic Total Occlusions in Infrainguinal Peripheral ArTeries

Last checked: Nov 19, 2026Latest source record: Jan 7, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

85

Actual

Start

Feb 13, 2018

Primary completion

Aug 8, 2019

Study completion Aug 8, 2019

Sponsor

Lead sponsor
ReFlow Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 18, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and effectiveness of the ReFlow Medical Wingman Catheter used to cross de novo or restenotic infrainguinal CTOs that cannot be crossed with a standard guidewire.

Conditions

  • Chronic Total Occlusion of Artery of the Extremities

Interventions

  • Wingman Crossing CatheterDevice

    Endovascular CTO crossing

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Lesions With Successful CTO Crossing Assessed by AngiographyTime frame: Intraprocedural
  2. Major Adverse Event (MAE) RateTime frame: Assessed from the time of the procedure through 30 days
  3. Rate of Clinically Significant PerforationsTime frame: Will be assessed from the time of the procedure through 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Adventist St. Helena Hospital

    St. Helena, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.